SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-241077
Filing Date
2024-10-22
Accepted
2024-10-22 16:21:31
Documents
15
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d842341d8k.htm   iXBRL 8-K 31920
2 EX-10.1 d842341dex101.htm EX-10.1 30960
  Complete submission text file 0001193125-24-241077.txt   256658

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacu-20241016.xsd EX-101.SCH 4878
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20241016_def.xml EX-101.DEF 15322
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20241016_lab.xml EX-101.LAB 26120
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20241016_pre.xml EX-101.PRE 16486
17 EXTRACTED XBRL INSTANCE DOCUMENT d842341d8k_htm.xml XML 9113
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241386577
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)